SOURCE: BIO-key International, Inc.

BIO-key International, Inc.

February 20, 2014 08:00 ET

World Class Healthcare Technology Providers Presenting BIO-key Fingerprint Authentication at HIMSS 2014

Compliance Requirements Driving Utilization of Biometric Authentication for ePrescriptions

WALL, NJ--(Marketwired - Feb 20, 2014) -  BIO-key International, Inc. (OTCQB: BKYI), a global leader in fingerprint biometric identification solutions, advanced mobile authentication and identity assurance technologies, today announced that the Company's healthcare integration partners including Allscripts (#3944), Caradigm (#1047), Epic (2139), HealthCast Solutions (#7045) and Key Source International (#1122) will be presenting our fingerprint authentication solutions for EHR and patient identification at HIMSS 2014, February 23rd - 27th, Orlando Convention Center, Orlando, Florida.

Visit BIO-key at the HealthCast Solutions booth to see a demonstration of fingerprint solutions for two-factor authentication and EPCS. A representative from Rady's Children's Hospital will be discussing the hospitals initial impression of HealthCast Solutions Single Sign-On and BIO-key's biometric fingerprint authentication. 

On Wednesday, February 26th visit the Allscripts booth between 9:30am and 1:00pm to witness live demonstrations and sample enrollments into Allscripts TouchWorks, Sunrise Clinical Manager and Professional EHR. Learn how your organization can replace cumbersome passwords with a secure and compliant biometric solution.

"Our products enhance productivity and efficiency. Leading hospitals utilize BIO-key to reduce the organizations' reliance on passwords, meet compliance requirements for two-factor authentication and EPCS while generating more time to care for patients and enhancing the overall security of patient records," said Jay Meier, Vice President, Corporate Development at BIO-key. "Organizations benefit from our unique ability to reduce the cost of hardware associated with existing authentication platforms and replace them with flexible, scalable and interoperable software. Interoperability protects the investment and prepares the hospital's IT department for the future of biometric authentication on mobile devices."

About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (

BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, wider market acceptance of biometric technologies, our ability to raise additional financing, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2012 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements whether to reflect events or circumstances after the date hereof or otherwise.

Contact Information